Zhaoming Liu

Title: Zhaoming Liu: Innovator in Vaccine Development

Introduction

Zhaoming Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of vaccine development, particularly in the fight against severe respiratory diseases.

Latest Patents

Zhaoming Liu holds a patent for a recombinant severe respiratory syndrome coronavirus 2 RBD trimer protein vaccine. This innovative vaccine is capable of generating broad-spectrum cross-neutralization activity against various SARS-CoV-2 epidemic strains. The invention provides a recombinant RBD trimer protein that serves as an antigen, supplemented with an adjuvant to immunize organisms. This process enables the generation of high-titer neutralizing antibodies that can effectively target multiple SARS-CoV-2 strains, offering potential treatment and prevention for SARS-CoV-2 infections and coronavirus disease 2019.

Career Highlights

Zhaoming Liu is associated with the National Vaccine and Serum Institute, where he continues to advance research in vaccine technology. His work is crucial in addressing public health challenges posed by emerging infectious diseases.

Collaborations

Zhaoming Liu collaborates with notable colleagues, including Qiming Li and Yu Liang, who contribute to his research efforts and innovations in vaccine development.

Conclusion

Zhaoming Liu's work in developing a versatile vaccine against SARS-CoV-2 highlights his commitment to improving global health. His innovative approach and collaboration with fellow researchers position him as a key figure in the ongoing battle against infectious diseases.